Skip to content
info@acplgroupindia.co.in +91-9266665201 Mon – Sat: 10:00 AM – 6:00 PM
Accredited Consultant
  • Home
  • About
  • Services

    • Regulatory Services

      • CDSCO Registration
      • FSSAI Licensing
      • BIS Certification
      • DGFT Approvals
      • WPC Approval
      • EPR Registration
      • Legal Metrology

    • Specialized Services

      • Pharmacovigilance
      • Cosmetovigilance
      • Materiovigilance
      • Food Safety Vigilance
      • Clinical Trials
      • Field Safety Trials

    • More Services

      • DSIR Recognition
      • ICMR Approvals
      • NPPA Compliance
      • Narcotics (CBN)
      • PCPNDT Compliance
      • India Entry Strategy
  • India Entry
  • Blog
  • Contact
Get Started
Accredited Consultant
  • Home
  • About
  • Services
    • Regulatory Services
      • CDSCO Registration
      • FSSAI Licensing
      • BIS Certification
      • DGFT Approvals
      • WPC Approval
      • EPR Registration
      • Legal Metrology
    • Specialized Services
      • Pharmacovigilance
      • Cosmetovigilance
      • Materiovigilance
      • Food Safety Vigilance
      • Clinical Trials
      • Field Safety Trials
    • More Services
      • DSIR Recognition
      • ICMR Approvals
      • NPPA Compliance
      • Narcotics (CBN)
      • PCPNDT Compliance
      • India Entry Strategy
  • India Entry
  • Blog
  • Contact
Call Us: +91-9266665201 info@acplgroupindia.co.in
  1. Home
  2. Tagged: narcotics compliance

Tagged: narcotics compliance

Regulatory updates, compliance insights, and industry analysis from the ACPL team.

Jul 6, 2026

NDPS Supply Chain Compliance: What the June 2026 Enforcement Wave Means for Pharma

India's June 2026 narcotics enforcement surge and the DCC-approved real-time tracking portal raise the bar for pharmaceutical supply chain compliance.

Read More
Jun 29, 2026

NDPS Controlled Substance Alert: New Registration Deadlines Hit in July 2026

A new controlled substance under NDPS was notified in March 2026 with stock and registration deadlines in July–August 2026. Here's…

Read More
May 4, 2026

NDPS Act Compliance for Pharma: Key Updates in 2025–26

India's NDPS regulatory landscape shifted significantly in late 2025 and early 2026. Here's what pharmaceutical companies must act on now.

Read More
Accredited Consultant

India's trusted pharma regulatory affairs consultancy. Over 25 years helping businesses navigate CDSCO, FSSAI, BIS, and all major Indian regulatory frameworks.

Quick Links

  • About ACPL
  • Our Services
  • India Entry Strategy
  • Insights & Blog
  • Contact Us
  • Careers

Key Services

  • CDSCO Registration
  • FSSAI Licensing
  • BIS Certification
  • Pharmacovigilance
  • Clinical Trials
  • EPR Registration

Contact Us

  • B-3, Sector-6, Noida – 201301, Uttar Pradesh, India
  • +91-9266665201
    +91-9310040434
  • info@acplgroupindia.co.in
  • Mon – Sat: 10:00 AM – 6:00 PM

© 2026 Accredited Consultants Private Limited. All rights reserved.

  • Privacy Policy
  • Terms & Conditions
Scroll to Top